Cargando…
Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time
Autores principales: | Tung, Norint P., Ma, Joseph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546788/ https://www.ncbi.nlm.nih.gov/pubmed/36098752 http://dx.doi.org/10.1007/s00228-022-03386-z |
Ejemplares similares
-
Response to: “Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time”
por: Kvitne, Kine Eide, et al.
Publicado: (2022) -
Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment
por: Li, Yan, et al.
Publicado: (2019) -
Cytochrome P450 CYP3A in human renal cell cancer
por: Murray, G I, et al.
Publicado: (1999) -
The cytochrome P450 (CYP) superfamily in cnidarians
por: Pankov, Kirill V., et al.
Publicado: (2021) -
Functional impact of cytochrome P450 3A (CYP3A) missense variants in cattle
por: Giantin, Mery, et al.
Publicado: (2019)